Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

An analysis of canines at Britain's Crufts show - held annually since the reign of Queen Victoria - found 74 percent were in ideal condition but 26 percent were overweight. None of the animals studied were underweight, researchers from the University of Liverpool reported in the journal Veterinary Record. The team reached their conclusions after studying 1,000 images of 28 dog breeds placed between first and fifth in their class during competitions from 2001 to 2013. The issue was most pronounced in certain breeds, with 80 percent of pugs, 68 percent of Basset hounds and 63 percent of Labradors proving excessively fat. While obesity at Crufts is still less common than in the general pet population, researcher Alex German said the proportion of overweight animals was a concern because show dogs were assumed to be perfect specimens of their breed. Obesity causes significant health problems in dogs, including arthritis and diabetes.
One in four dogs at top show Crufts found to be overweight.

The story provided several estimates for the cost of gastric banding; it also discussed insurance coverage, i.e. that the procedure was not always covered by insurance. While the story mentioned weight loss, health improvement, and longer life, it failed to provide quantitative estimates for these. The story provided quantitative information on the disease reduction obtained with the use of this device in individuals with type II diabetes. Although the story did mention that weight loss is slower with gastric banding than with gastric bypass, itfailed to provide quantitative information about the amount or rate of weight loss attained with banding. The story should also have mentioned that long-term followup finds for those whose diabetes resolves following gastric banding, about half re-develop diabetes at 10 years. The story mentioned weight regain as well as some of the side effects that occur with the use of this device. For a more complete discussion, it should have included information about how frequently these occur. When discussing the effect of gastric banding on type II diabetes, the story mentioned the research about the use of this device for this population. It mentioned the evidence about safety and effectiveness and where it had been published. As for the impact of the banding procedure on weight, the story neglected to include information on the average weight loss seen but did include several patient anecdotes. However the story was more focused on the marketing strategies for this device rather than the health claims per se. The story did not engage in disease mongering. The story included primary quotes from clinicians, industry spokespersons, and individuals who had undergone gastric banding. The story included a pretty comprehensive comparison between gastric banding and gastric bypass, another type of weight loss surgery. It only mentioned diet and exercise in passing and failed to mention medication that can be used for weight loss. The story provided a very complete discussion about the various venues at which gastric banding was available. The story provided a pretty complete history of the use of gastric banding. Does not rely on a press release
Industry Giants Push Obesity Surgery

The findings, from a small but unique study in Botswana, could influence care in Africa and other regions hit hard by the virus. They also might offer a clue in scientists' quest for a cure. The Harvard-led team found super early treatment limits how HIV takes root in a newborn's body, shrinking the "reservoir" of virus that hides out, ready to rebound if those youngsters ever stop their medications. "We don't think the current intervention is itself curative, but it sets the stage" for future attempts, said Dr. Daniel Kuritzkes of Boston's Brigham and Women's Hospital, who co-authored the study. Giving pregnant women a cocktail of anti-HIV drugs can prevent them from spreading the virus to their unborn children, a step that has dramatically reduced the number of babies born with the virus worldwide. Still, some 300 to 500 infants are estimated to be infected every day in sub-Saharan Africa. Doctors have long known that treating babies in the first weeks to months of life is important, because their developing immune systems are especially vulnerable to HIV. But an infant dubbed the "Mississippi baby" raised a critical question: Should treatment start even earlier? The girl received a three-drug combination within 30 hours of her birth in July 2010, highly unusual for the time. Her family quit treatment when she was a toddler yet her HIV remained in remission for a remarkable 27 months before she relapsed and restarted therapy. The Botswana study was one of several funded by the U.S. National Institutes of Health after doctors learned of the Mississippi baby, to further explore very early treatment. The findings are encouraging, said Dr. Deborah Persaud, a pediatric HIV specialist at Johns Hopkins University who wasn't involved with the Botswana study but helped evaluate the Mississippi baby. "The study showed what we hypothesized happened in the Mississippi baby, that very early treatment really prevents establishment of these long-lived reservoir cells that currently are the barrier to HIV eradication," Persaud said. She cautioned: "Very early treatment is important, but prevention should still be our top priority." In Botswana, researchers tested at-risk newborns, enrolling 40 born with HIV, treating them within hours to a few days, and tracking them for two years. On Wednesday, they reported results from the first 10 patients, comparing them with 10 infants getting regular care treatment beginning when they were a few months old. Medication brought HIV under control in both groups. But the children treated earliest had a much smaller reservoir of HIV in their blood, starting about six months into treatment, the researchers reported in Science Translational Medicine. The earliest-treated children also got another benefit: more normal functioning of some key parts of the immune system. One big question: Did the HIV reservoir shrink enough to make a long-term difference? To find out, next year the researchers will give these children experimental antibodies designed to help keep HIV in check, and test how they fare with a temporary stop to their anti-HIV drugs. In the U.S., Europe and South Africa, it's becoming common to test at-risk infants at birth. But in most lower-income countries, babies aren't tested until they're 4 to 6 weeks old, said study co-author Dr. Roger Shapiro, a Harvard infectious disease specialist. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.
Study: For babies born with HIV, start treatment right away.